Numinus Wellness Inc. (TSX:NUMI)
Canada · Delayed Price · Currency is CAD 0.0500
+0.0150 (42.86%)
At close: Jan 29, 2025
Numinus Wellness Income Statement
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 |
| 6.49 | 4.17 | 3.75 | 6.49 | 1.51 | 0.88 | |
Revenue Growth (YoY) | - | 11.08% | -42.21% | 329.03% | 71.78% | 719.87% |
Cost of Revenue | 3.8 | 3 | 2.16 | 4.72 | 1.6 | 0.8 |
Gross Profit | 2.69 | 1.17 | 1.59 | 1.78 | -0.08 | 0.08 |
Selling, General & Admin | 7 | 11.78 | 20.09 | 23.91 | 12.09 | 5.04 |
Research & Development | 0 | 0.03 | 1.17 | 1.89 | 1.4 | 0.02 |
Operating Expenses | 7.31 | 13.08 | 24.05 | 30.23 | 15.76 | 7.37 |
Operating Income | -4.63 | -11.92 | -22.46 | -28.45 | -15.84 | -7.28 |
Interest Expense | -0.14 | -0.1 | -0.17 | -0.56 | -0.11 | -0.14 |
Interest & Investment Income | 0.02 | 0.01 | 0 | 0 | - | 0.01 |
Currency Exchange Gain (Loss) | -0.02 | -0.06 | -0.07 | 0.21 | - | - |
Other Non Operating Income (Expenses) | 0.94 | 0.11 | -0.28 | 0.01 | -0.02 | 0.02 |
EBT Excluding Unusual Items | -3.83 | -11.96 | -22.98 | -28.78 | -15.98 | -7.4 |
Merger & Restructuring Charges | - | - | - | -2.52 | -0.27 | - |
Impairment of Goodwill | - | - | - | -13.23 | -1.58 | - |
Gain (Loss) on Sale of Investments | -0.49 | -1.23 | - | - | - | - |
Gain (Loss) on Sale of Assets | -8.41 | -0.93 | -0.25 | - | - | 0.04 |
Asset Writedown | -0.17 | -0.17 | - | -0.37 | -0.9 | - |
Other Unusual Items | -0.3 | -0.3 | -0.01 | -0.02 | -0.05 | -2.25 |
Pretax Income | -13.2 | -14.6 | -23.24 | -44.92 | -18.77 | -9.61 |
Income Tax Expense | - | - | - | -0.03 | - | -0.01 |
Earnings From Continuing Operations | -13.2 | -14.6 | -23.24 | -44.88 | -18.77 | -9.6 |
Earnings From Discontinued Operations | -1.4 | -5.04 | -7.02 | - | - | - |
Net Income | -14.6 | -19.64 | -30.26 | -44.88 | -18.77 | -9.6 |
Net Income to Common | -14.6 | -19.64 | -30.26 | -44.88 | -18.77 | -9.6 |
Shares Outstanding (Basic) | 316 | 295 | 264 | 217 | 165 | 64 |
Shares Outstanding (Diluted) | 316 | 295 | 264 | 217 | 165 | 64 |
Shares Change (YoY) | 18.50% | 11.95% | 21.72% | 31.31% | 158.48% | -11.48% |
EPS (Basic) | -0.05 | -0.07 | -0.11 | -0.21 | -0.11 | -0.15 |
EPS (Diluted) | -0.05 | -0.07 | -0.11 | -0.21 | -0.11 | -0.15 |
Free Cash Flow | -3.92 | -12.46 | -22.99 | -27.48 | -16.22 | -5.39 |
Free Cash Flow Per Share | -0.01 | -0.04 | -0.09 | -0.13 | -0.10 | -0.08 |
Gross Margin | 41.46% | 27.98% | 42.45% | 27.36% | -5.39% | 9.41% |
Operating Margin | -71.34% | -285.89% | -598.39% | -438.10% | -1046.54% | -826.43% |
Profit Margin | -225.21% | -471.23% | -806.23% | -691.12% | -1240.29% | -1089.51% |
Free Cash Flow Margin | -60.51% | -298.91% | -612.67% | -423.09% | -1071.59% | -611.76% |
EBITDA | -4.62 | -11.44 | -21.46 | -27.88 | -15.47 | -6.84 |
EBITDA Margin | -71.21% | -274.36% | - | - | - | - |
D&A For EBITDA | 0.01 | 0.48 | 0.99 | 0.57 | 0.37 | 0.44 |
EBIT | -4.63 | -11.92 | -22.46 | -28.45 | -15.84 | -7.28 |
EBIT Margin | -71.34% | -285.89% | - | - | - | - |
Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.